JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Mini-ureteroneocystostomy: a safe and effective outpatient treatment for unilateral vesicoureteral reflux.

Journal of Urology 2008 October
PURPOSE: Medically refractory vesicoureteral reflux is a common condition that can be cured by open surgery. Extravesical ureteroneocystostomy is a safe and effective surgical procedure. We determined whether this could be accomplished with limited dissection via an approximately 2 cm inguinal incision (mini-ureteroneocystostomy).

MATERIALS AND METHODS: All patients with unilateral vesicoureteral reflux who underwent mini-ureteroneocystostomy from 2003 to 2007 were evaluated. We present preoperative characteristics, surgical technique and outcomes in this analysis.

RESULTS: From 2003 to 2007, 57 children underwent mini-ureteroneocystostomy for unilateral vesicoureteral reflux. The group was predominantly female (48 of 57 patients or 84%) with median age of 4.8 years. Median vesicoureteral reflux grade was 3 (range 2 to 5). Duplication anomalies were present in 8 patients, while 5 had a Hutch diverticulum and 5 had a solitary kidney. A total of 47 patients (82%) underwent postoperative voiding cystourethrogram and surgical cure was achieved in all. De novo vesicoureteral reflux was identified in the contralateral ureter in 3 of 47 patients (6%). The procedure was performed on an outpatient basis in 47 of 57 patients (82%). Postoperative complications requiring surgical intervention developed in 2 children.

CONCLUSIONS: Mini-ureteroneocystostomy is an effective modified extravesical technique for vesicoureteral reflux. This procedure is safe and it can be performed on an outpatient basis with excellent results. It has become our standard of care in patients with unilateral vesicoureteral reflux.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app